Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…
Nose to Brain CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the concept remains preclinical and unproven in children. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but human pediatric safety, dosing, and efficacy data remain absent. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox-Gastaut Syndromes, Promise Before Proof
medical cannabis research: A 2026 review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the clinical evidence remains preclinical and translational. It keeps the evidence readable for…